| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2023 | 92.31% | Piper Sandler | $10 → $6 | Maintains | Overweight |
| 05/31/2023 | 124.36% | TD Cowen | → $7 | Initiates Coverage On | → Outperform |
| 05/16/2023 | 124.36% | BTIG | $8 → $7 | Maintains | Buy |
| 04/20/2023 | 156.41% | BTIG | $8 → $8 | Maintains | Buy |
| 03/24/2023 | — | William Blair | Initiates Coverage On | → Outperform | |
| 03/09/2023 | 156.41% | BTIG | $12 → $8 | Maintains | Buy |
| 03/06/2023 | 220.51% | Piper Sandler | $15 → $10 | Maintains | Overweight |
| 11/09/2022 | 284.62% | BTIG | → $12 | Maintains | Buy |
| 10/31/2022 | 348.72% | BTIG | → $14 | Maintains | Buy |
| 08/26/2022 | 380.77% | BTIG | $13 → $15 | Maintains | Buy |
| 07/18/2022 | 476.92% | Oppenheimer | → $18 | Assumes | → Outperform |
| 11/29/2021 | 476.92% | Oppenheimer | → $18 | Initiates Coverage On | → Outperform |
| 11/29/2021 | 380.77% | BTIG | → $15 | Initiates Coverage On | → Buy |
| 11/29/2021 | 380.77% | Piper Sandler | → $15 | Initiates Coverage On | → Overweight |
What is the target price for MDxHealth (MDXH)?
The latest price target for MDxHealth (NASDAQ: MDXH) was reported by Piper Sandler on November 9, 2023. The analyst firm set a price target for $6.00 expecting MDXH to rise to within 12 months (a possible 92.31% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MDxHealth (MDXH)?
The latest analyst rating for MDxHealth (NASDAQ: MDXH) was provided by Piper Sandler, and MDxHealth maintained their overweight rating.
When is the next analyst rating going to be posted or updated for MDxHealth (MDXH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MDxHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MDxHealth was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating MDxHealth (MDXH) correct?
While ratings are subjective and will change, the latest MDxHealth (MDXH) rating was a maintained with a price target of $10.00 to $6.00. The current price MDxHealth (MDXH) is trading at is $3.12, which is out of the analyst's predicted range.